Financial giants have made a conspicuous bearish move on Cencora. Our analysis of options history for Cencora (NYSE:COR) revealed 11 unusual trades.
Delving into the details, we found 9% of traders were bullish, while 72% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $136,290, and 8 were calls, valued at $275,820.
What's The Price Target?
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $220.0 and $230.0 for Cencora, spanning the last three months.
Insights into Volume & Open Interest
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Cencora's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Cencora's substantial trades, within a strike price spectrum from $220.0 to $230.0 over the preceding 30 days.
Cencora Call and Put Volume: 30-Day Overview
Noteworthy Options Activity:
About Cencora
Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the us pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
Having examined the options trading patterns of Cencora, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
Where Is Cencora Standing Right Now?
- Currently trading with a volume of 1,759,822, the COR's price is down by -3.41%, now at $229.18.
- RSI readings suggest the stock is currently is currently neutral between overbought and oversold.
- Anticipated earnings release is in 42 days.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Cencora with Benzinga Pro for real-time alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
